查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401908

2030 年病毒学检测市场预测：按产品类型、技术、诊断技术、方法、应用、最终用户和地区进行的全球分析

Virology Testing Market Forecasts to 2030 - Global Analysis By Product Type, Procedure, Diagnostic Technique, Method, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球病毒学检测市场规模为 127 亿美元，预计预测期内复合年增长率为 3.8%，到 2030 年将达到 164 亿美元。

病毒学检测是指用于检测、识别和研究生物样本中病毒的诊断过程和实验室技术。这些测试有助于识别特定病毒的存在，确定病毒的类型和病毒株，并评估对病毒感染的免疫反应。此外，病毒学检测可以帮助确定感染者最有效的抗病毒治疗方法，并有助于制定管理病毒性疾病的个人化医疗方法。病毒学检测对于筛检捐血是否有爱滋病毒、B型肝炎和C型肝炎等血源性病毒以及确保输血安全至关重要。

根据世界卫生组织（WHO）预测，2021年全球60%的人口将患有感染疾病。

病毒感染疾病增加

全球病毒感染疾病日益流行是病毒学检测市场成长的关键因素。流感、HIV、肝炎以及最近的 COVID-19 大大流行等感染疾病的持续出现，推动了对准确、及时的诊断解决方案的需求。随着病毒感染持续对公共卫生构成严重挑战，迫切需要能够快速识别和区分各种病毒的先进病毒学检测方法。此外，病毒学检测在疾病监测中发挥至关重要的作用，帮助卫生专业人员就治疗、遏制措施和公共卫生干预措施做出明智的资讯。

高成本

病毒学检测的高成本是病毒学检测市场的主要抑制因素，影响了医疗保健提供者和患者的可用性和负担能力。先进的病毒学检测方法，特别是PCR（聚合酶炼式反应）和次世代定序等分子诊断技术，通常涉及昂贵的试剂、设备和技术人员。与病毒学检测相关的经济负担可能导致检测延迟、监测不足和病毒感染漏报。此外，它可能会阻碍强有力的公共卫生策略的製定，并阻碍有效控制和管理病毒爆发的能力。

技术进步

在病毒学检测市场，技术进步正在彻底改变诊断能力，提高病毒检测的准确性和效率。聚合酶炼式反应（PCR）技术大大改进，使得快速、准确地鑑定病毒的遗传物质成为可能。此外，创新的即时检测设备的开发促进了更快、更分散的诊断，特别是在大流行期间。自动化和机器人化简化了实验室工作流程，缩短了周转时间并提高了测试吞吐量。这些技术进步在全球健康中发挥着至关重要的作用，不仅有助于病毒感染的早期和准确诊断，而且还支持监测活动和加强大流行的防范。

抗生素抗药性

抗生素抗药性是病毒学检测市场中重要但间接的问题。病毒学检测主要着重于识别和诊断未经抗生素治疗的病毒感染。然而，在临床实践中，当病毒感染疾病患者错误地服用抗生素时，就会出现问题。滥用或过度使用抗生素会导致抗生素抗药性的产生，这是细菌进化以抵抗抗生素作用的现象。如果无法有效地进行病毒学检测来确定感染疾病的病毒性质，则可能会不必要地开立抗生素。这种管理不善会助长抗生素抗药性，并对公共卫生构成广泛威胁。

COVID-19 的影响

COVID-19大流行对病毒学检测市场产生了重大影响，推动了全球对诊断解决方案的前所未有的需求。迫切需要大规模检测来识别病毒并阻止其传播，导致各种病毒学检测方法的采用激增，包括 PCR 检测、抗原检测和血清学检测。这种不断增长的需求正在推动新测试技术的快速创新和开发。

细胞培养方法领域预计在预测期内规模最大

细胞培养方法部分估计占据最大占有率。细胞培养方法是病毒学检测的基础和必备技术，在病毒分离、传播和研究中发挥至关重要的作用。该过程以病毒样本接种细胞，并为病毒生长和复製提供最佳条件。当病毒在宿主细胞内繁殖时，可能会发生可观察到的变化，包括细胞毒性作用。细胞培养能够辨识和表征病毒，可用于诊断分析、疫苗和抗病毒药物的开发。此外，它将促进病毒行为和发病机制的研究，以及潜在治疗性介入的评估。

预计被动预防在预测期内的复合年增长率最高。

预计被动预防领域将在预测期内出现良好成长。被动预防在病毒学检测市场中发挥着至关重要的作用，它与诊断检测一起提供了补充策略来预防和控制病毒感染。在病毒学检测的背景下，被动预防是针对有接触特定病毒风险的个体的预防措施。病毒学检测市场受益于被动预防的整合，它为病毒感染控制提供了全面的方法。此外，随着对有效抗病毒解决方案的需求不断增长，被动预防有助于形成多方面的策略，并加强了医疗保健专业人员可用于预防和治疗的工具套件。

占有率最高的地区

由于尖端测试和诊断技术的快速采用、医疗保健支出的增加、支持性政府法规的存在、最先进的临床实验室的存在以及存在，北美预计将成为预测期内最大的市场製造公司。我们得到了市场占有率。推动市场扩张的另一个重要因素是美国公共和私人机构研发活动的活性化。

复合年增长率最高的地区：

由于诊断和医疗保健领域的显着增长和进步，预计亚太地区在预测期内将出现有益增长。医疗保健意识的提高、医疗保健成本的上升以及医疗保健基础设施的改善正在推动对病毒学检测的需求。亚太地区正在爆发感染疾病，需要高效、快速的病毒学检测来及早发现和遏制。对预防性医疗保健和公共卫生措施的日益重视进一步增加了该地区对病毒学检测解决方案的需求。

免费客製化服务：

如果您订阅此报告，我们将为您提供以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球病毒学检测市场：依产品类型

  • 介绍
  • 检测套件
  • 装置
  • 消耗品

第六章全球病毒学检测市场：依方法论

  • 介绍
  • 抗原检测
  • 细胞培养方法
  • 特异性抗体检测
  • 基因序列测定
  • 病毒核酸检测
  • 血凝试验

第七章全球病毒学检测市场：依诊断技术分类

  • 介绍
  • 基于免疫检测的方法
  • 基于质谱的方法
  • 分子诊断方法
    • 基于NGS的方法
    • 基于PCR的方法
  • 其他诊断技术

第八章全球病毒学检测市场：依方法

  • 介绍
  • 被动预防
  • 积极预防
  • 免疫预防
  • 干扰素
  • 抗病毒化疗

第九章全球病毒学检测市场：依应用分类

  • 介绍
  • 呼吸道感染疾病
  • 皮肤和软组织感染疾病
  • 尿道感染
  • 胃肠道感染疾病
  • 性行为感染传染病
  • 眼部感染疾病
  • 周产期感染疾病

第10章全球病毒学测试市场：依最终用户分类

  • 介绍
  • 诊所
  • 医院
  • 诊断中心
  • 实验室
  • 血库
  • 药局

第十一章全球病毒学检测市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司简介

  • Bio-Rad Laboratories Inc
  • Abbot Healthcare
  • F. Hoffmann-La Roche AG
  • Fujirebio Diagnostics Inc.
  • Cepheid
  • Hologic Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen
  • bioMerieux SA
  • Siemens Healthineers
  • Diasorin
  • Trinity Biotech
  • Vircell
  • Biospherix, Ltd
  • Novogene Co Ltd.
Product Code: SMRC24428

According to Stratistics MRC, the Global Virology Testing Market is accounted for $12.7 billion in 2023 and is expected to reach $16.4 billion by 2030 growing at a CAGR of 3.8% during the forecast period. Virology testing refers to the diagnostic processes and laboratory techniques used to detect, identify, and study viruses in biological samples. These tests help identify the presence of specific viruses, determine the type and strain of the virus, and assess the immune response to viral infections. Moreover, virology testing assists in determining the most effective antiviral treatments for infected individuals, contributing to personalized medicine approaches to managing viral diseases. Virology testing is essential in screening blood donations for the presence of blood-borne viruses such as HIV, hepatitis B, and hepatitis C, ensuring the safety of blood transfusions.

According to the World Health Organization (WHO), in 2021, 60% of the global population was suffering from infectious diseases.

Market Dynamics:

Driver:

Rising prevalence of viral infections

The increasing prevalence of viral infections worldwide is a significant driver for the growth of the virology testing market. The persistent emergence of infectious diseases, including influenza, HIV, hepatitis, and, more recently, the global COVID-19 pandemic, has heightened the demand for accurate and timely diagnostic solutions. As viral infections continue to pose significant public health challenges, there is a pressing need for advanced virology testing methods that can swiftly identify and differentiate various viruses. Moreover, virology testing plays a pivotal role in disease surveillance, aiding healthcare professionals in making informed decisions regarding treatment, containment measures, and public health interventions.

Restraint:

High cost

The high cost of virology tests is a significant restraint in the virology testing market, impacting accessibility and affordability for both healthcare providers and patients. Advanced virology testing methods, particularly molecular diagnostic techniques like PCR (Polymerase Chain Reaction) and next-generation sequencing, often involve expensive reagents, equipment, and skilled personnel. The financial burden associated with virology testing may lead to delays in testing, inadequate surveillance, and underreporting of viral infections. Moreover, it could impede the development of robust public health strategies, hindering the ability to effectively control and manage viral outbreaks.

Opportunity:

Technological advancements

In the virology testing market, technological advancements have revolutionized diagnostic capabilities, enhancing the precision and efficiency of virus detection. Polymerase chain reaction (PCR) techniques have undergone significant refinements, enabling the rapid and accurate identification of viral genetic material. Furthermore, the development of innovative point-of-care testing devices has facilitated quicker and more decentralized diagnostics, particularly during pandemics. Automation and robotics have streamlined laboratory workflows, reducing turnaround times and enhancing testing throughput. These technological strides not only contribute to the early and precise diagnosis of viral infections but also play a pivotal role in global health by supporting surveillance efforts and bolstering pandemic preparedness.

Threat:

Antibiotic resistance

Antibiotic resistance is a critical concern within the virology testing market, albeit indirectly. Virology testing primarily focuses on identifying and diagnosing viral infections, which are not treated with antibiotics. However, the issue arises in clinical practice when patients with viral infections are mistakenly prescribed antibiotics. The misuse and overuse of antibiotics contribute to the development of antibiotic resistance, a phenomenon where bacteria evolve to withstand the effects of these medications. If virology tests are not employed effectively to identify the viral nature of an infection, antibiotics may be unnecessarily prescribed. This mismanagement fuels antibiotic resistance, posing a broader threat to public health.

COVID-19 Impact

The COVID-19 pandemic has profoundly impacted the virology testing market, triggering unprecedented demand for diagnostic solutions worldwide. The urgent need for large-scale testing to identify and contain the spread of the virus has led to a surge in the adoption of various virology testing methods, including PCR assays, antigen tests, and serological tests. This increased demand has prompted rapid innovation and the development of new testing technologies.

The cell culture method segment is expected to be the largest during the forecast period

The cell culture method segment is estimated to hold the largest share. The cell culture method is a fundamental and indispensable technique in virology testing, playing a pivotal role in the isolation, propagation, and study of viruses. The process involves inoculating the cells with a viral sample and providing optimal conditions for viral growth and replication. As the virus multiplies within the host cells, observable changes, such as cytopathic effects, may occur. Cell culture allows for the identification and characterization of viruses, aiding in the development of diagnostic assays, vaccines, and antiviral drugs. Additionally, it facilitates the study of viral behavior, pathogenesis, and the evaluation of potential therapeutic interventions.

The passive prophylaxis segment is expected to have the highest CAGR during the forecast period

The passive prophylaxis segment is anticipated to have lucrative growth during the forecast period. Passive prophylaxis plays a pivotal role in the virology testing market, offering a complementary strategy alongside diagnostic testing to prevent and manage viral infections. In the context of virology testing, passive prophylaxis serves as a preventive measure for individuals at risk of exposure to specific viruses. The virology testing market benefits from the integration of passive prophylaxis by offering a comprehensive approach to viral infection management. Moreover, as the demand for effective antiviral solutions continues to grow, passive prophylaxis contributes to a multi-faceted strategy, enhancing the arsenal of tools available to healthcare professionals for both prevention and treatment.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the quick adoption of cutting-edge testing and diagnostic techniques, increased healthcare spending, the existence of supportive government regulations, the existence of cutting-edge clinical laboratories, and the existence of manufacturing firms. Another significant element boosting the market's expansion is the rise in R&D activity from both public and private institutions in the US.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to significant growth and advancements in diagnostics and healthcare. The increasing awareness of healthcare, rising healthcare expenditures, and improvements in healthcare infrastructure drive the demand for virology testing. The Asia-Pacific region also experiences outbreaks of infectious diseases, necessitating efficient and rapid virology testing for early detection and containment. The growing emphasis on preventive healthcare and the implementation of public health initiatives further fuel the demand for virology testing solutions in this region.

Key players in the market:

Some of the key players in the Virology Testing Market include Bio-Rad Laboratories Inc, Abbot Healthcare, F. Hoffmann-La Roche AG, Fujirebio Diagnostics Inc. , Cepheid, Hologic Inc., Thermo Fisher Scientific Inc., Qiagen, bioMerieux SA, Siemens Healthineers, Diasorin, Trinity Biotech, Vircell, Biospherix, Ltd and Novogene Co Ltd.

Key Developments:

In August 2023, Abbott has partnered with Redcliffe Labs to launch Clinical Decision Support (CDS), also known as AlinIQ, which is powered by unique technologies such as Big Data Engines and Artificial Intelligence (AI).

In February 2022, Abbott, the global healthcare leader, announced new collaborations with key health-tech partners BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher a new era of holistic diabetes management care.

Product Types Covered:

  • Assay Kits
  • Instruments
  • Consumables

Procedures Covered:

  • Antigen Detection
  • Cell Culture Method
  • Specific Antibodies Detection
  • Gene Sequencing
  • Virus Nucleic Acid Detection
  • Hemagglutination Assays

Diagnostic Techniques Covered:

  • Immunoassay-based Method
  • Mass Spectroscopy-based Method
  • Molecular Diagnostics Method
  • Other Diagnostic Techniques

Methods Covered:

  • Passive Prophylaxis
  • Active Prophylaxis
  • Immunoprophylaxis
  • Interferon's
  • Antiviral Chemotherapy

Applications Covered:

  • Respiratory Tract Infections
  • Skin and Soft Tissue Infections
  • Urinary Tract Infection
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Eye Infections
  • Perinatal Infections

End Users Covered:

  • Clinics
  • Hospitals
  • Diagnostic Centers
  • Laboratories
  • Blood Banks
  • Pharmacies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virology Testing Market, By Product Type

  • 5.1 Introduction
  • 5.2 Assay Kits
  • 5.3 Instruments
  • 5.4 Consumables

6 Global Virology Testing Market, By Procedure

  • 6.1 Introduction
  • 6.2 Antigen Detection
  • 6.3 Cell Culture Method
  • 6.4 Specific Antibodies Detection
  • 6.5 Gene Sequencing
  • 6.6 Virus Nucleic Acid Detection
  • 6.7 Hemagglutination Assays

7 Global Virology Testing Market, By Diagnostic Technique

  • 7.1 Introduction
  • 7.2 Immunoassay-based Method
  • 7.3 Mass Spectroscopy-based Method
  • 7.4 Molecular Diagnostics Method
    • 7.4.1 NGS-based methods
    • 7.4.2 PCR-based methods
  • 7.5 Other Diagnostic Techniques

8 Global Virology Testing Market, By Method

  • 8.1 Introduction
  • 8.2 Passive Prophylaxis
  • 8.3 Active Prophylaxis
  • 8.4 Immunoprophylaxis
  • 8.5 Interferon's
  • 8.6 Antiviral Chemotherapy

9 Global Virology Testing Market, By Application

  • 9.1 Introduction
  • 9.2 Respiratory Tract Infections
  • 9.3 Skin and Soft Tissue Infections
  • 9.4 Urinary Tract Infection
  • 9.5 GI Tract Infections
  • 9.6 Sexually Transmitted Diseases
  • 9.7 Eye Infections
  • 9.8 Perinatal Infections

10 Global Virology Testing Market, By End User

  • 10.1 Introduction
  • 10.2 Clinics
  • 10.3 Hospitals
  • 10.4 Diagnostic Centers
  • 10.5 Laboratories
  • 10.6 Blood Banks
  • 10.7 Pharmacies

11 Global Virology Testing Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Bio-Rad Laboratories Inc
  • 13.2 Abbot Healthcare
  • 13.3 F. Hoffmann-La Roche AG
  • 13.4 Fujirebio Diagnostics Inc.
  • 13.5 Cepheid
  • 13.6 Hologic Inc.
  • 13.7 Thermo Fisher Scientific Inc.
  • 13.8 Qiagen
  • 13.9 bioMerieux SA
  • 13.10 Siemens Healthineers
  • 13.11 Diasorin
  • 13.12 Trinity Biotech
  • 13.13 Vircell
  • 13.14 Biospherix, Ltd
  • 13.15 Novogene Co Ltd.

List of Tables

  • Table 1 Global Virology Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Virology Testing Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Virology Testing Market Outlook, By Assay Kits (2021-2030) ($MN)
  • Table 4 Global Virology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global Virology Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 6 Global Virology Testing Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 7 Global Virology Testing Market Outlook, By Antigen Detection (2021-2030) ($MN)
  • Table 8 Global Virology Testing Market Outlook, By Cell Culture Method (2021-2030) ($MN)
  • Table 9 Global Virology Testing Market Outlook, By Specific Antibodies Detection (2021-2030) ($MN)
  • Table 10 Global Virology Testing Market Outlook, By Gene Sequencing (2021-2030) ($MN)
  • Table 11 Global Virology Testing Market Outlook, By Virus Nucleic Acid Detection (2021-2030) ($MN)
  • Table 12 Global Virology Testing Market Outlook, By Hemagglutination Assays (2021-2030) ($MN)
  • Table 13 Global Virology Testing Market Outlook, By Diagnostic Technique (2021-2030) ($MN)
  • Table 14 Global Virology Testing Market Outlook, By Immunoassay-based Method (2021-2030) ($MN)
  • Table 15 Global Virology Testing Market Outlook, By Mass Spectroscopy-based Method (2021-2030) ($MN)
  • Table 16 Global Virology Testing Market Outlook, By Molecular Diagnostics Method (2021-2030) ($MN)
  • Table 17 Global Virology Testing Market Outlook, By NGS-based methods (2021-2030) ($MN)
  • Table 18 Global Virology Testing Market Outlook, By PCR-based methods (2021-2030) ($MN)
  • Table 19 Global Virology Testing Market Outlook, By Other Diagnostic Techniques (2021-2030) ($MN)
  • Table 20 Global Virology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 21 Global Virology Testing Market Outlook, By Passive Prophylaxis (2021-2030) ($MN)
  • Table 22 Global Virology Testing Market Outlook, By Active Prophylaxis (2021-2030) ($MN)
  • Table 23 Global Virology Testing Market Outlook, By Immunoprophylaxis (2021-2030) ($MN)
  • Table 24 Global Virology Testing Market Outlook, By Interferon's (2021-2030) ($MN)
  • Table 25 Global Virology Testing Market Outlook, By Antiviral Chemotherapy (2021-2030) ($MN)
  • Table 26 Global Virology Testing Market Outlook, By Application (2021-2030) ($MN)
  • Table 27 Global Virology Testing Market Outlook, By Respiratory Tract Infections (2021-2030) ($MN)
  • Table 28 Global Virology Testing Market Outlook, By Skin and Soft Tissue Infections (2021-2030) ($MN)
  • Table 29 Global Virology Testing Market Outlook, By Urinary Tract Infection (2021-2030) ($MN)
  • Table 30 Global Virology Testing Market Outlook, By GI Tract Infections (2021-2030) ($MN)
  • Table 31 Global Virology Testing Market Outlook, By Sexually Transmitted Diseases (2021-2030) ($MN)
  • Table 32 Global Virology Testing Market Outlook, By Eye Infections (2021-2030) ($MN)
  • Table 33 Global Virology Testing Market Outlook, By Perinatal Infections (2021-2030) ($MN)
  • Table 34 Global Virology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 Global Virology Testing Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 36 Global Virology Testing Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 Global Virology Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 38 Global Virology Testing Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 39 Global Virology Testing Market Outlook, By Blood Banks (2021-2030) ($MN)
  • Table 40 Global Virology Testing Market Outlook, By Pharmacies (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.